SMS Lifesciences Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20212022
EBITDA3236
EBIT2439
Earning Per Share4483
Expenses235316
Net Profit1425
Net Profit Margin57
Operating Profit Margin1210
Profit Before Tax2033
Dividends Per Share22
Operation Revenue267352

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
2023008,560.84NA9,408.43
2023002,835.49NA4,038.35
202300372.90NA385.50
202300103.87NA140.39
20221,257.602,182.90978.507,628.101,190
The EBITDA of SMS Lifesciences is 36 as of 12/8/2023
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
2019202020212023
Operating Activities30153515
Investing Activities-44-27-26-31
Financing Activities1512-317
Others0000
Net Cash Flow1-060

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
20234,959.33-7,943.682,376.07-608.28
20223,325.90-1,871.88-1,599.79-145.77
2023723.95-447.59-261.9614.40
2020140.90-44.50-38.5557.85
2017640-498.50-177.50-36
The cash flow from Operating Activities of SMS Lifesciences is 15 as of 12/8/2023